Importantly H661 cells were approximately as sensitive to copanlisib as the PIK3CA mutated BT474 breast cancer cell line, which is the most sensitive cell line to copanlisib that we have found to date [37]. This evidence concerns the gene PIK3CA and breast carcinoma.